EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$7.05
-0.42 (-5.62%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+627.5% upside
Low Target
$37.24
Average Target
$51.29
High Target
$70.77
Current Price
$7.05
Current
$7.05
$7.05
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Scenario Analysis
Bear Case
$37.24
428.2%
Low target
Base Case
$51.29
+627.5%
Avg target
Bull Case
$70.77
+903.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.31
-24.3% from high
52-Week Low
$3.86
+82.6% from low
Target vs 52W High
$51.29
+450.9% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.06
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals